Search research articles
Contact Us
Filters
Showing results (11-20 of 258) with videos related to
Page
of 26
Sort By:
Clinical and Translational Gastroenterology
|
November 27, 2019
Response to Liu et al
Mark O Goodarzi, David C Whitcomb
Drugs
|
July 6, 2023
Diabetes of the Exocrine Pancreas: Implications for Pharmacological Management
Mark O Goodarzi, Maxim S Petrov
Diabetes, Obesity & Metabolism
|
October 13, 2005
Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents
Mark O Goodarzi, Michael Bryer-Ash
JAMA
|
November 6, 2008
Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?
Mark O Goodarzi, Bruce M Psaty
Fertility and Sterility
|
May 16, 2016
Genetic determinants of polycystic ovary syndrome: progress and future directions
Michelle R Jones, Mark O Goodarzi
Fertility and Sterility
|
August 12, 2003
The importance of insulin resistance in polycystic ovary syndrome
Mark O Goodarzi, Stanley G Korenman
Circulation Research
|
May 22, 2020
Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease
Mark O Goodarzi, Jerome I Rotter
American Journal of Obstetrics and Gynecology
|
March 27, 2021
Polycystic ovary syndrome and breast cancer subtypes: a Mendelian randomization study
Tiantian Zhu, Jinrui Cui, Mark O Goodarzi
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 2008
Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome
Mark O Goodarzi, Ning Xu, Ricardo Azziz
The Journal of Steroid Biochemistry and Molecular Biology
|
July 11, 2014
DHEA, DHEAS and PCOS
Mark O Goodarzi, Enrico Carmina, Ricardo Azziz
Page
of 26
Search research articles
Search
Showing results (11-20 of 258) with videos related to
Sort By:
Page
of 26
Clinical and Translational Gastroenterology
|
November 27, 2019
Response to Liu et al
Mark O Goodarzi, David C Whitcomb
Drugs
|
July 6, 2023
Diabetes of the Exocrine Pancreas: Implications for Pharmacological Management
Mark O Goodarzi, Maxim S Petrov
Diabetes, Obesity & Metabolism
|
October 13, 2005
Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents
Mark O Goodarzi, Michael Bryer-Ash
JAMA
|
November 6, 2008
Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?
Mark O Goodarzi, Bruce M Psaty
Fertility and Sterility
|
May 16, 2016
Genetic determinants of polycystic ovary syndrome: progress and future directions
Michelle R Jones, Mark O Goodarzi
Fertility and Sterility
|
August 12, 2003
The importance of insulin resistance in polycystic ovary syndrome
Mark O Goodarzi, Stanley G Korenman
Circulation Research
|
May 22, 2020
Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease
Mark O Goodarzi, Jerome I Rotter
American Journal of Obstetrics and Gynecology
|
March 27, 2021
Polycystic ovary syndrome and breast cancer subtypes: a Mendelian randomization study
Tiantian Zhu, Jinrui Cui, Mark O Goodarzi
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 2008
Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome
Mark O Goodarzi, Ning Xu, Ricardo Azziz
The Journal of Steroid Biochemistry and Molecular Biology
|
July 11, 2014
DHEA, DHEAS and PCOS
Mark O Goodarzi, Enrico Carmina, Ricardo Azziz
Page
of 26